Johnson & Johnson is a global American pharmaceutical and consumer goods company with headquarters in New Brunswick, New Jersey. The company is listed in the Dow Jones Industrial Average.
According to Johnson & Johnson's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.87875. At the end of 2023 the company had a P/S ratio of 4.06.
Year | P/S ratio | Change |
---|---|---|
2023 | 4.06 | -19.95% |
2022 | 5.07 | 5.51% |
2021 | 4.80 | -4.27% |
2020 | 5.02 | 7.21% |
2019 | 4.68 | 11.12% |
2018 | 4.21 | -14.23% |
2017 | 4.91 | 12.61% |
2016 | 4.36 | 7.49% |
2015 | 4.06 | 3.59% |
2014 | 3.92 | 8.08% |
2013 | 3.62 | 25.03% |
2012 | 2.90 | 5.21% |
2011 | 2.75 | -0.15% |
2010 | 2.76 | -3.94% |
2009 | 2.87 | 10.25% |
2008 | 2.60 | -16.02% |
2007 | 3.10 | -13.44% |
2006 | 3.58 | 1.22% |
2005 | 3.54 | -11.07% |
2004 | 3.98 | 8.65% |
2003 | 3.66 | -16.61% |
2002 | 4.39 | -20.75% |
2001 | 5.54 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Novartis NVS | 3.98 | 2.57% | ๐จ๐ญ Switzerland |
Pfizer PFE | 2.68 | -30.87% | ๐บ๐ธ USA |
Abbott Laboratories ABT | 4.58 | 18.14% | ๐บ๐ธ USA |
Medtronic MDT | 3.32 | -14.29% | ๐ฎ๐ช Ireland |
Eli Lilly LLY | 21.1 | 442.78% | ๐บ๐ธ USA |
Sanofi SNY | 2.45 | -36.79% | ๐ซ๐ท France |
Gilead Sciences GILD | 3.00 | -22.54% | ๐บ๐ธ USA |
Stryker Corporation SYK | 6.07 | 56.50% | ๐บ๐ธ USA |
Merck MRK | 5.40 | 39.34% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | 2.34 | -39.79% | ๐ฌ๐ง UK |